Our website is currently configured to place cookies on your computer. For more information about cookies and how to disable cookies, see our cookie policyHide this message in future
Dr Hilary Jones says the results from trials of ipilimumab and nivolumab on cancer patients are very exciting and much more promising than previous tests.